RECENT ADVANCES IN THE MOLECULAR GENETICS OF UROGENITAL TUMORS

No abstract is available for this paper.

• Publication year

  1994

• Venue

  International journal of urology

• Publication date

  1994-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1442-2042.1994.tb00001.xPMID 7627831
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chromosome study of five cancers of the prostate

  2004cited by this paper
• Allelic deletions in renal tumors: histopathological correlations.

  1993cited by this paper
• Susceptibility to renal carcinoma in the Eker rat involves a tumor suppressor gene on chromosome 10.

  1993cited by this paper
• Evidence for two bladder cancer suppressor loci on human chromosome 9.

  1993cited by this paper
• No germline TP53 mutations detected in familial and bilateral testicular cancer.

  1993cited by this paper
• Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour

  1993cited by this paper
• Distinct pattern of p53 mutations in bladder cancer: relationship to tobacco usage.

  1993cited by this paper
• Role of chromosome 9 in human bladder cancer.

  1993cited by this paper
• WT-1 is required for early kidney development.

  1993cited by this paper
• Over‐expression of p53 nuclear oncoprotein in transitional‐cell bladder cancer and its prognostic value

  1993cited by this paper
• Influence of cigarette smoking and schistosomiasis on p53 gene mutation in urothelial cancer.

  1993cited by this paper
• A novel insertional mutation at the third zinc finger coding region of the WT1 gene in Denys-Drash syndrome.

  1993cited by this paper
• p53 gene alterations in human prostate carcinoma.

  1993cited by this paper
• Screening of human bladder tumors and urine sediments for the presence of H‐ras mutations

  1993cited by this paper
• A Novel Renal Cell Carcinoma Susceptibility Gene Maps on Chromosome 10 in the Eker Rat

  1993cited by this paper
• No germline TP53 mutations detected in familial and bilateral testicular cancer

  1993cited by this paper
• Homozygous deletions within 9p21-p22 identify a small critical region of chromosomal loss in human malignant mesotheliomas.

  1993cited by this paper
• Identification of the von Hippel-Lindau disease tumor suppressor gene.

  1993cited by this paper
• Relaxation of imprinted genes in human cancer

  1993cited by this paper
• Chromosome 17p deletions and p53 mutations in renal cell carcinoma.

  1993cited by this paper
• Genomic imprinting and gene activation in cancer

  1993cited by this paper
• Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer.

  1993cited by this paper
• Unusual distribution of chromosome 12 in a testicular germ-cell tumor cell line (833K) and its cisplatin-resistant derivative (64CP9).

  1993cited by this paper
• Loss of heterozygosity at the short arm of chromosome 3 in renal‐cell cancer correlates with the cytological tumour type

  1993cited by this paper
• Metachronous multifocal development of urothelial cancers by intraluminal seeding.

  1993cited by this paper
• Antioncogenes and human cancer.

  1993cited by this paper
• Loss of RB protein expression in primary bladder cancer correlates with loss of heterozygosity at the RB locus and tumor progression

  1993cited by this paper
• p53 protein accumulation and gene mutation in the progression of human prostate carcinoma.

  1993cited by this paper
• Tumor suppressor gene allelic loss in human renal cancers.

  1993cited by this paper
• Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression.

  1993cited by this paper
• p53 Gene Mutations in Chinese Human Testicular Seminoma

  1993cited by this paper
• Accumulated allelic losses in the development of invasive urothelial cancer

  1993cited by this paper
• Mutation of H-ras is infrequent in bladder cancer: confirmation by single-strand conformation polymorphism analysis, designed restriction fragment length polymorphisms, and direct sequencing.

  1993cited by this paper
• Genetic alterations in bladder cancer.

  1993cited by this paper
• Mutations of the p53 gene do not occur in testis cancer.

  1993cited by this paper
• Antioncogenes and human cancer.

  1993cited by this paper
• The multistep nature of cancer.

  1993cited by this paper
• Preliminary mapping of the deleted region of chromosome 9 in bladder cancer.

  1993cited by this paper
• p53 function and dysfunction.

  1992cited by this paper
• Androgen receptor gene mutations in human prostate cancer.

  1992cited by this paper
• Transcriptional regulation. A closer look at E2F.

  1992cited by this paper
• An immunohistologic evaluation of C‐erbB‐2 gene product in patients with urinary bladder carcinoma

  1992cited by this paper
• Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma.

  1992cited by this paper
• Inherited WT1 mutation in Denys-Drash syndrome.

  1992cited by this paper
• Molecular Genetics of Cancer

  1992cited by this paper
• Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer.

  1992cited by this paper
• Allelic deletions in the long arm of chromosome 12 identify sites of candidate tumor suppressor genes in male germ cell tumors.

  1992cited by this paper
• Homozygous deletions within human chromosome band 9p21 in melanoma.

  1992cited by this paper
• Allelic losses at chromosome 17p in human renal cell carcinoma are inversely related to allelic losses at chromosome 3p.

  1992cited by this paper
• Constitutional mutations in the WT1 gene in patients with Denys-Drash syndrome.

  1992cited by this paper
• Interleukin-6 in renal cell carcinoma.

  1992cited by this paper
• Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1.

  1992cited by this paper
• Zinc finger point mutations within the WT1 gene in Wilms tumor patients.

  1992cited by this paper
• Low chromosome number in chromophobe renal cell carcinomas

  1992cited by this paper
• Frequent association of p53 gene mutation in invasive bladder cancer.

  1992cited by this paper
• A closer look at E2F

  1992cited by this paper
• Germline intronic and exonic mutations in the Wilms' tumour gene (WT1) affecting urogenital development

  1992cited by this paper
• Cytogenetic analysis of 124 prospectively ascertained male germ cell tumors.

  1992cited by this paper
• Wilms' tumour: reconciling genetics and biology.

  1992cited by this paper
• Infrequent Mutation of p53 Gene in Human Renal Cell Carcinoma Detected by Polymerase Chain Reaction Single‐strand Conformation Polymorphism Analysis

  1992cited by this paper
• Cytogenetic analysis of 57 primary prostatic adenocarcinomas

  1992cited by this paper
• Carcinogens leave fingerprints

  1992cited by this paper
• Molecular and cellular characterization of human renal cell carcinoma cell lines.

  1992cited by this paper
• Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer.

  1992cited by this paper
• Loss of the 17p chromosomal region in a metastatic carcinoma of the prostate.

  1992cited by this paper
• Allelic loss of chromosome 17p in urothelial cancer: strong association with invasive phenotype.

  1992cited by this paper
• Clonal origin of bladder cancer.

  1992cited by this paper
• A third Wilms' tumor locus on chromosome 16q.

  1992cited by this paper
• Alterations of the P53 gene are associated with the progression of a human prostate carcinoma.

  1992cited by this paper
• c-erbB-2 amplification and identical p53 mutations in concomitant transitional carcinomas of renal pelvis and urinary bladder.

  1992cited by this paper
• Nonlinkage of 16q markers to familial predisposition to Wilms' tumor.

  1992cited by this paper
• Small subgroup of aggressive, highly proliferative prostatic carcinomas defined by p53 accumulation.

  1992cited by this paper
• Numerical chromosome 1, 7, 9, and 11 aberrations in bladder cancer detected by in situ hybridization.

  1991cited by this paper
• Common regions of deletion on chromosomes 5q, 6q, and 10q in renal cell carcinoma.

  1991cited by this paper
• Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies.

  1991cited by this paper
• Activated ras alleles in human carcinoma of the prostate are rare.

  1991cited by this paper
• Enhanced expression of interleukin-6 in primary human renal cell carcinomas.

  1991cited by this paper
• Allelotyping of human prostatic adenocarcinoma.

  1991cited by this paper
• Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles.

  1991cited by this paper
• Genetic analysis as an aid in diagnosis for patients with midline carcinomas of uncertain histologies.

  1991cited by this paper
• Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma

  1991cited by this paper
• Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladder.

  1991cited by this paper
• p53 mutations in human cancers.

  1991cited by this paper
• Autonomous growth of androgen-independent human prostatic carcinoma cells: role of transforming growth factor alpha.

  1991cited by this paper
• Expression of the Wilms' tumor gene WT1 in the murine urogenital system.

  1991cited by this paper
• Amplification at chromosome 11q13 in transitional cell tumours of the bladder.

  1991cited by this paper
• Identification of p53 gene mutations in bladder cancers and urine samples.

  1991cited by this paper
• The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells.

  1991cited by this paper
• WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour

  1991cited by this paper
• Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas.

  1991cited by this paper
• Allelic loss at chromosome 3p characterizes clear cell phenotype of renal cell carcinoma.

  1991cited by this paper
• Oncogenes in human testicular cancer: DNA and RNA studies.

  1991cited by this paper
• Evidence for WT1 as a Wilms tumor (WT) gene: intragenic germinal deletion in bilateral WT.

  1991cited by this paper
• Molecular genetic alterations in superficial and locally advanced human bladder cancer.

  1991cited by this paper
• Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome.

  1991cited by this paper
• Uniparental paternal disomy in a genetic cancer-predisposing syndrome

  1991cited by this paper
• The p53 tumour suppressor gene

  1991cited by this paper
• From gene to carcinogen: a rapidly evolving field in molecular epidemiology.

  1991cited by this paper
• Participation of p53 protein in the cellular response to DNA damage.

  1991cited by this paper
• Autocrine regulation of DU145 human prostate cancer cell growth by epidermal growth factor‐related polypeptides

  1991cited by this paper

• The impact of smoking on male lower urinary tract symptoms (LUTS)

  2020cites this paper
• Wnt signaling and senescence: A tug of war in early neoplasia?

  2008cites this paper
• Downregulation of Wnt signaling is a trigger for formation of facultative heterochromatin and onset of cell senescence in primary human cells.

  2007cites this paper
• Predicting disease outcome of non‐invasive transitional cell carcinoma of the urinary bladder using an artificial neural network model: Results of patient follow‐up for 15 years or longer

  2003cites this paper
• Distinct patterns of chromosomal losses in clinically synchronous and asynchronous bilateral renal cell carcinoma.

  2002cites this paper
• AgNOR Count in Resting Cells (Resting NOR) Is a New Prognostic Marker in Invasive Bladder Tumor

  2001cites this paper
• Allelic Imbalances on Chromosome 20 in Human Transitional Cell Carcinoma

  2000cites this paper
• [p53 tumor suppressor gene mutation and prognosis in 105 cases of bladder cancer--the relationship between mutation of the p53 gene with clinicopathological features and smoking].

  1999cites this paper
• Role of volume weighted mean nuclear volume for predicting disease outcome in patients with renal cell carcinoma.

  1997cites this paper
• [Overexpression of c-erbB-2 and p53 oncoprotein in renal pelvic and ureteral carcinomas with reference to the expression of Ki-67 antigen as a proliferation marker].

  1997cites this paper
• 腎盂尿管癌におけるc-erbB-2, p53遺伝子産物の過剰発現とKi-67による細胞増殖動態の検討

  1997cites this paper
• Prognostic criteria in patients with prostate cancer: Gleason score versus volume-weighted mean nuclear volume.

  1997cites this paper
• Transitional Cell Tumor and p53

  1996cites this paper
• FAMILIAL RENAL CELL CARCINOMA: REVIEW OF RECENT MOLECULAR GENETICS

  1995cites this paper